Financial reports
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
ARS
2022 FY
Annual report to shareholders
7 Apr 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
4 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Thermo Fisher Scientific Reports Fourth Quarter 2023 Results
31 Jan 24
8-K
Entry into a Material Definitive Agreement
5 Dec 23
8-K
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
7 Nov 23
8-K
Thermo Fisher Scientific Reports Third Quarter 2023 Results
25 Oct 23
8-K
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
17 Oct 23
8-K/A
Departure of Directors or Certain Officers
21 Sep 23
8-K
Entry into a Material Definitive Agreement
10 Aug 23
8-K
Regulation FD Disclosure
8 Aug 23
8-K
Thermo Fisher Scientific Reports Second Quarter 2023 Results
26 Jul 23
8-K
Departure of Directors or Certain Officers
13 Jul 23
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
6 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
1 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
31 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
4 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
22 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
15 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
12 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
1 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
30 Nov 23
Proxies
DEFA14A
Additional proxy soliciting materials
7 Apr 23
DEF 14A
Definitive proxy
7 Apr 23
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEF 14A
Definitive proxy
7 Apr 22
DEFA14A
Additional proxy soliciting materials
8 Apr 21
DEF 14A
Definitive proxy
8 Apr 21
DEFA14A
Additional proxy soliciting materials
7 Apr 20
DEF 14A
Definitive proxy
7 Apr 20
DEFA14A
Additional proxy soliciting materials
9 Apr 19
DEF 14A
Definitive proxy
9 Apr 19
Other
SD
Conflict minerals disclosure
30 May 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
23 Feb 23
CERT
Certification of approval for exchange listing
22 Nov 22
UPLOAD
Letter from SEC
14 Oct 22
CORRESP
Correspondence with SEC
6 Oct 22
UPLOAD
Letter from SEC
22 Sep 22
SD
Conflict minerals disclosure
27 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
24 Feb 22
SD
Conflict minerals disclosure
28 May 21
Ownership
4
Joseph R. Holmes
27 Mar 24
4
Science 37 Holdings, Inc.
14 Mar 24
4
Science 37 Holdings, Inc.
14 Mar 24
3/A
Science 37 Holdings, Inc.
14 Mar 24
SC 13D/A
Science 37 Holdings, Inc.
14 Mar 24
4
MARC N CASPER
14 Mar 24
4
MARC N CASPER
13 Mar 24
4
Lisa P. Britt
13 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
144
Notice of proposed sale of securities
12 Mar 24